Migraine with aura

光环 皮质扩散性抑郁症 先兆偏头痛 心理学 偏头痛 医学 冲程(发动机) 麻醉 听力学 机械工程 工程类
作者
Christian Lucas
出处
期刊:Revue Neurologique [Elsevier BV]
卷期号:177 (7): 779-784 被引量:30
标识
DOI:10.1016/j.neurol.2021.07.010
摘要

Around 15% to one-third of migraineurs experience aura. Aura is a fully reversible focal neurological phenomenon involving visual, sensory, speech, and/or motor symptoms that develops gradually and usually precedes the headache phase. The pivotal role of cortical spreading depression (CSD) as a mechanism underlying aura has been widely supported by a large body of studies. The diagnosis is based on the International Headache Classification Disorders III edition criteria. Aura is characterized by gradual development, duration of each symptom no longer than one hour, a mix of positive and negative features, and complete reversibility. Visual aura is the most common type of aura, occurring in over 90% of patients. When aura symptoms are multiple, they usually follow one another in succession, beginning with visual, then sensory, then aphasic; but the reverse and other orders have been noted. The accepted duration for most aura symptoms is one hour, but motor symptoms, which are rare, are often longer lasting. When a patient experiences for the first time a possible aura phase it's sometimes difficult to know if there was gradual or brutal onset of the symptoms. If the patient has no visual aura symptoms or simultaneous neurological symptoms, or presents neurological symptoms corresponding to a cerebral vascular territory, emergency exploration of a possible transient ischemic attack is necessary. Long duration (greater than one hour) of what may or may not be an aura phase, late onset of aura, or a dramatic increase in aura attacks should also be explored. The relative risk of ischemic stroke is significantly increased in migraine with aura. Combined hormonal contraception with estrogens significantly increases the risk of stroke in women with migraine with aura. It is recommended to start non-steroidal anti-inflammatory drugs (NSAIDs) or aspirin as soon as possible during the aura phase, not to treat the aura, but to avoid or to diminish the headache phase. In case of failure of NSAIDs or aspirin it is recommended to use a triptan when the headache begins. The prophylactic treatments for migraine with aura are those used in migraine without aura based on very few randomized clinical trials specifically dedicated to migraine with aura.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
秀儿完成签到,获得积分10
刚刚
果粒红豆豆完成签到,获得积分10
刚刚
小林关注了科研通微信公众号
1秒前
1秒前
萌妹发布了新的文献求助10
1秒前
mei发布了新的文献求助10
1秒前
hmv发布了新的文献求助10
1秒前
苏浩然完成签到,获得积分10
1秒前
搜集达人应助xL采纳,获得10
2秒前
祖逸凡完成签到,获得积分10
2秒前
星辰大海应助iveuplife采纳,获得10
3秒前
丁浩伦发布了新的文献求助10
3秒前
3秒前
zhangj696应助zl52采纳,获得20
3秒前
西大喜完成签到,获得积分10
3秒前
4秒前
Candy发布了新的文献求助10
4秒前
5秒前
爆米花应助青夏采纳,获得10
5秒前
5秒前
徐梓睿应助科研通管家采纳,获得30
5秒前
大个应助科研通管家采纳,获得10
5秒前
丘比特应助科研通管家采纳,获得10
5秒前
研友_VZG7GZ应助科研通管家采纳,获得10
5秒前
鸣笛应助科研通管家采纳,获得20
5秒前
李健应助科研通管家采纳,获得10
6秒前
随遇而安应助micaixing2006采纳,获得10
6秒前
浮游应助科研通管家采纳,获得10
6秒前
海绵发布了新的文献求助10
6秒前
6秒前
思源应助科研通管家采纳,获得10
6秒前
鸣笛应助科研通管家采纳,获得10
6秒前
6秒前
丘比特应助科研通管家采纳,获得10
6秒前
youjun发布了新的文献求助10
6秒前
爆米花应助科研通管家采纳,获得10
6秒前
香蕉觅云应助科研通管家采纳,获得10
7秒前
大个应助科研通管家采纳,获得10
7秒前
上官若男应助科研通管家采纳,获得10
7秒前
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Manipulating the Mouse Embryo: A Laboratory Manual, Fourth Edition 1000
计划经济时代的工厂管理与工人状况(1949-1966)——以郑州市国营工厂为例 500
Comparison of spinal anesthesia and general anesthesia in total hip and total knee arthroplasty: a meta-analysis and systematic review 500
INQUIRY-BASED PEDAGOGY TO SUPPORT STEM LEARNING AND 21ST CENTURY SKILLS: PREPARING NEW TEACHERS TO IMPLEMENT PROJECT AND PROBLEM-BASED LEARNING 500
Modern Britain, 1750 to the Present (第2版) 300
Writing to the Rhythm of Labor Cultural Politics of the Chinese Revolution, 1942–1976 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 物理化学 基因 催化作用 遗传学 冶金 电极 光电子学
热门帖子
关注 科研通微信公众号,转发送积分 4585432
求助须知:如何正确求助?哪些是违规求助? 4002122
关于积分的说明 12389406
捐赠科研通 3678232
什么是DOI,文献DOI怎么找? 2027162
邀请新用户注册赠送积分活动 1060707
科研通“疑难数据库(出版商)”最低求助积分说明 947227